Gabrielnyc.com Science

London, UK (PRWEB) January 24, 2012

Today, digital channels offer life science companies enormous untapped opportunities to reach and interwork with physicians and patients. Some marketing teams have already responded by boosting their digital activity, with growth trends indicating that some digital channels will surpass more traditional media tools.

However, a host of challenges faced by the industry like regulatory compliance, ROI, adverse events monitoring, etc. leave companies behind the curve as they try to navigate both opportunities and hidden dangers. Meanwhile, leading-edge firms forge ahead by integrating digital tools into overall brand – and corporate-level strategies.

New research study ?Pharmaceutical Digital Marketing and Social Media? worked out by Cutting Edge Information has been recently published by Market Publishers Ltd.

Report Details:

Title: Pharmaceutical Digital Marketing and Social Media

Published: December, 2011

Pages: 187

Price: US$ 7,695.00

http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/healthcare_equipment_services/pharmaceutical_digital_marketing_n_social_media.html

The report is a must-have for those who want to:

????explore real-world marketing mixes, case studies and rankings to understand industry-wide usage and goals for digital marketing, social media and mobile technology;
????learn how leading companies manage compliance, gauge ROI and avoid outsourcing pitfalls; as well as explore how digital models help teams mitigate regulatory risks and earn internal buy-in for new initiatives.;
????benchmark structure, staffing, budget and reporting lines to develop a team equipped to face challenges both now and in the future.

Report Contents:

Executive Summary

Study Methodology

Study DeUnitions

Digital Marketing: Key Findings and Recommendations

Integrating Digital and Traditional Channels

The New Pharmaceutical Marketing Mix

Social Media and Mobile Technology in Pharma

Pharma?s In-Roads into Social Media

Mobile Technology

eMarketing Structure, Stafung and Budgets

eMarketing Organizational Structure

eMarketing StafUng Resources

Digital Marketing Budgets

Outsourcing Digital Marketing

Agency Ratings: Six Categories for Digital Success

Structural Strategies for Mitigating Digital Marketing Risk

Charts and Graphics

Executive Summary

Figure E.1: Digital and Traditional Channels as a Percentage of the Overall 2011 Marketing Media Mix

Figure E.2: Media Mix for All Companies from 2009-2011

Digital Marketing: Key Findings and Recommendations

Figure E.3: Percentage Change in Media Mix from 2009 to 2011

Figure E.4: Dedicated eMarketing Groups? Staffing (FTEs)

Figure E.5: Total eMarketing Budgets

Figure E.6: Brand-Level eMarketing Spending During Registration & Launch

Figure E.7: Percentage of Companies Engaged in At Least One Type of Social Media Activity

Figure E.8: Ratings of Challenges to Social Media Adoption

Figure E.9: Effect of Lack of FDA Guidance on Companies? DTC Social Media Strategy

Figure E.10: Overall Opinion of Contract Agency?s Ability to Carry Out Pharmaceutical Digital Marketing

Integrating Digital and Traditional Channels

Figure 1.1: Age of Dedicated eMarketing Groups

The New Pharmaceutical Marketing Mix

Figure 1.2: Media Mix for All Companies from 2009-2011

Figure 1.3: Percentage Change in Media Mix from 2009 to 2011

Figure 1.4: Media Mix for Top 10 Companies from 2009-2011

Figure 1.5: Media Mix for Top 50 Companies from 2009-2011

Figure 1.6: Media Mix for Top 100 Companies from 2009-2011

Figure 1.7: Media Mix for US Companies from 2009-2011

Figure 1.8: Media Mix for Non-US Companies from 2009-2011

Figure 1.9: Media Mix for Brand-level Groups from 2009-2011

Figure 1.10: Media Mix for Corporate-level Groups from 2009-2011

Social Media and Mobile Technology in Pharma

Pharma?s In-Roads into Social Media

Figure 2.1: Percentage of Companies Engaged in At Least One Type of Social Media Activity

Figure 2.2: Number of Companies Engaged in Each Type of Social Media Activity

Figure 2.3: Companies Engaged in Each Type of Social Media Activity, by Percentage

Figure 2.4: Companies Engaged in Each Type of Social Media Activity at Corporate and Brand Levels

Figure 2.5: Ratings of Positive Impact Potential of Social Media, by Activity Type

Figure 2.6: Ratings Spread of Positive Impact Potential of Social Media, by Activity Type

Figure 2.7: Ratings of Challenges to Social Media Adoption

Figure 2.8: Ratings Spread of Challenges to Social Media Adoption

Figure 2.9: How Companies Measure Social Media Initiatives

Figure 2.10: Effect of Lack of FDA Guidance on Companies? DTC Social Media Strategy

Figure 2.11: Effect of Lack of FDA Guidance on Companies? DTC Social Media Strategy (US vs Non-US)

Figure 2.12: Support for Regulatory and Non-Regulatory Options

Figure 2.13: Ratings of Marketing Potential of Online Channels

Figure 2.14: Employee Use of Social Media and Formal Policies

Mobile Technology

Figure 2.15: Percentage of Brands Using Mobile Technology for Marketing or Medical Affairs Initiatives

…

More new studies by the publisher can be found at Cutting Edge Information page.

###